药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pipecuronium
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Eliglustat.
Pipecuronium
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Eliglustat.
Pipecuronium
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Eliglustat.
Pipecuronium
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Eliglustat.
Pipecuronium
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Eliglustat.
Pipecuronium
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Eliglustat.
Pipecuronium
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Eliglustat.
Pipecuronium
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Eliglustat.
Pipecuronium
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Eliglustat.
Pipecuronium
Talinolol
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Eliglustat.
Pipecuronium
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Eliglustat.
Pipecuronium
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Eliglustat.
Pipecuronium
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Eliglustat.
Pipecuronium
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Eliglustat.
Pipecuronium
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Eliglustat.
Pipecuronium
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Eliglustat.
Pipecuronium
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Eliglustat.
Pipecuronium
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Eliglustat.
Pipecuronium
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Eliglustat.
Pipecuronium
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Eliglustat.